PCOS is a disease condition in which the ovaries of the women have altered morphology in USG, mostly beaded appearance. Apart from that there is alteration in LH-FSH ratio that is presented in the form of symptoms like oligomenorrhoea,anovulation, etc.

Pharmaceutical analytical standardisation and safety evaluation of "SHEETALA-10" granule in "AARTAVADUSHTI" wsr PCOS

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046149

Enrollment

Registered

2022-10-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome Health Condition 2: E282- Polycystic ovarian syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Unmarried and Married women 2)Reproductive age group of 20-35 years 3)Basal Metabolioc Index between 18-25/meter square

Exclusion criteria

Exclusion criteria: 1)Patient not willing for trial 2)Patient with other causes of Androgen Excess 3)Patients having Thyroid problems 4)Patients having cardiovascular diseases 5)Tuberculosis patient 6)Diabetic patient Patients suffering from carcinomas

Design outcomes

Primary

Measure	Time frame
cure of menstrual irregularities, acne, hyperglycemia, obesityTimepoint: 12 weeks	—

Secondary

Measure	Time frame
improvement in menstrual irregularities, acne, obesity, hyperglycaemia,Improved general health cost-effective treatment Improve routine activityTimepoint: 4 weeks,8 weeks	—

Countries

India

Contacts

Public ContactDr Anjana saxena

Govt.PG Ayurveda College and Hospital Varanasi

dr.spandey2007@gmail.com9417077401

Outcome results